4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-24-033705
Options or other derivatives
- Chief Science Officer acquired 80,744 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PICKER DONALD H Chief Science Officer | 2024-11-04 | Grant or award · Stock option (right to buy) | +40,000 | 66,358 | D | ||
| PICKER DONALD H Chief Science Officer | 2024-11-04 | Grant or award · Restricted Stock Units | +35,000 | 101,358 | D | ||
| PICKER DONALD H Chief Science Officer | 2024-10-25 | Grant or award · Performance Based Restricted Stock Units | +5,744 | 107,102 | D | ||
Loading xslF345X05/rdgdoc.xml…